That's a false dichotomy.
I'm not going to support Monsanto's IP actions here, but they aren't pure evil the way, say, De Beers is.
The reason for the gene is to ensure Monsanto's share price continues to rise, by ensuring a recurring stream of income from a product that was never previously purchased beyond initial implementation.
Hence, false dichotomy.